ask="1.80"
ask_size="3300"
average_daily_volume="43298"
bid="N/A"
bid_size="N/A"
book_value="0.69"
change="-0.06"
change_from_200_day_moving_average="-0.03"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-2.05"
change_From_52_week_low="0.41"
change_in_percent="-3.55%"
close="1.63"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.29M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="1.73"
high_52_weeks="3.68"
last_trade_date="3/10/2017"
last_trade_price="1.63"
last_trade_size="238"
last_trade_time="4:00pm"
low="1.63"
low_52_weeks="1.22"
market_capitalization="17.91M"
moving_average_200_day="1.66"
moving_average_50_day="1.74"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.73"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.56%"
percent_change_from_50_day_moving_average="-6.34%"
percent_change_from_52_week_high="-55.71%"
percent_change_from_52_week_low="+33.61%"
previous_close="1.69"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.47"
price_per_sales="5.28"
revenue="3.52M"
shares_outstanding="10987000"
short_ratio="0.11"
stock_exchange="NCM"
symbol="CBLI"
volume="5805"
weeks_range_52="1.22 - 3.68"
